Before submitting an abstract, please refer to the full list of abstract submission categories.
Abstract Submission Categories
For questions about specific submission categories, contact the appropriate sponsoring society:
Authors do not have to be a member of one of the four sponsoring societies to submit an abstract. Submissions from international or trainee authors are welcome.
The following types of abstracts are eligible for submission:
- Abstracts containing basic, clinical or translational research findings in the fields of gastroenterology, hepatology, endoscopy or gastrointestinal surgery may be submitted.
- Abstracts featuring case reports or clinical vignettes may be submitted. Please note that case studies may not be submitted as late-breaking abstracts.
- Abstracts presented at national meetings held outside of the U.S. (e.g., APDW, EASL, UEG Week, VNAGE, etc.) may be submitted to DDW.
- Abstracts that have been submitted to DDW in previous years, but not accepted for presentation, may be submitted.
Abstracts will not be considered for presentation at DDW 2018 if they have been or will be presented before DDW at a national society meeting taking place in the U.S. (e.g., ACG Annual Meeting, The Liver Meeting) with the exceptions of the ACS Surgical Forum, the NASPGHAN Annual Meeting and the Crohn’s & Colitis Congress™.
Email the DDW Program team if you wish to verify that your abstract is eligible for submission to DDW 2018.
To offer attendees up-to-the-minute research findings, DDW will accept late-breaking basic and clinical abstracts from Thursday, Feb. 1, 2018, through Thursday, Feb. 15, 2018. Late-breaking abstract submissions should feature the latest high-impact science that will have an immediate and significant effect upon researchers and practitioners. Late-breaking abstracts will be judged jointly by representatives of all four sponsoring societies and may be selected for oral or poster presentation at DDW 2018. Abstract reviewers will evaluate late-breaking submissions on the quality of the science described with particular attention to novelty and potential for immediate impact upon the GI community.
The late-breaking submission period is not an extension to the general submission period; rather, only substantive abstracts that contain results not available at the Dec. 1 general abstract submission deadline will be considered. Case studies, vignettes or revisions to previously submitted abstracts will not be considered and should not be submitted. There is a $120 non-refundable processing charge per late-breaking abstract.